GCR 100 2020 out now

Airlines attack Sabre/Farelogix deal

FTC loses bid to stall Evonik/PeroxyChem

The stuff of nightmares: The Tipline for 28 January 2020

Axon tries to short-circuit FTC process, US argues

Illumina/PacBio: killing a killer acquisition, or the birth of nascent competition enforcement?

Coordinated action taken by the US Federal Trade Commission and the UK Competition and Markets Authority against Illumina’s proposed acquisition of Pacific Biosciences indicates that both antitrust enforcers are significantly increasing their focus on deals involving nascent competition. Other agencies are likely to follow suit. Crowell & Moring partners Alexis Gilman, Sean-Paul Brankin, Olivier Antoine, and associates Evi Mattioli and Eric Ashby look at the aggressive enforcement theories behind scrutiny of this merger.

Q&A with Kristen Limarzi - Part II

Gibson Dunn & Crutcher partner Kristen Limarzi spoke with GCR USA last month about what she wishes she had gotten to do while at the US Department of Justice's antitrust division; which topics she is watching closely in mergers, civil conduct and cartels; and how she measures success.

Litigators of the week: Kellogg Hansen Todd Figel & Frederick

Supreme Court justice Brett Kavanaugh is not known for an expansive view of the federal antitrust laws, but he sided with iPhone users bringing antitrust claims – a win for their counsel at Kellogg Hansen Todd Figel & Frederick.

Hot Docs – Hovenkamp, hospital-home bias and a healthy dose of judicial review

While the recent heatwave may have you inside by the air-conditioning all day, we have collected the hottest docs in antitrust to keep you entertained.